 |
Email: aiste.bulavaite@bti.vu.lt
ORCID
ResearchGate
|
| Research Interests: |
Studies on epidemiology and virulence factors of Gardnerella spp. Generation and characterization of recombinant viral and bacterial proteins in yeast and E.coli. |
| Present Position: |
Researcher, Institute of Biotechnology, Life Sciences Center, Vilnius University |
Education:
|
2001 - BSc in Biology, Vilnius University
2003 - MSc in Biology, Vilnius University
2008 - PhD in Biochemistry, Vilnius University |
| Experience (Past Positions): |
2001–2003 Technician, Institute of Biotechnology
2007–2018 Research assistant, Institute of Biotechnology, Vilnius University
2018–present - Researcher, Institute of Biotechnology, Vilnius University |
| Publications: |
LABT_LMAVB PubMed |
|
Projects and Grants:
|
Principal project implementer in the projects supported by the Research Council of Lithuania:
2020–2023 - Studies on the virulence potential of meningococcal isolates: implications for an improved molecular diagnostics of invasive meningococcal disease 01.2.2-LMT-K-718-03-0036.
2017–2020 - The prevalence and distribution of virulence factors among subgroups of vaginal bacteria Gardnerella vaginalis S-MIP-17-49.
2013–2015 - Synthesis of Schmallenberg Virus Proteins and Their Application for Diagnostic Means MIP-044/2013.
2012–2014 - High-Throughput Screening of Antibody-Secreting Cells Using Droplet-Based Microfluidics, MIP-048/2012.
2011–2012 - Analysis and diagnostics of new human Parvoviridea family viruses, MIP-060/2011.
2010–2011 - The analysis of distribution of gammaretrovirus XMRV and development of virus-specific antibody assay MIP-75/2010.
Principal implementer in the project supported by the Lithuanian Science and Study Foundation:
2008–2010 - The role and diagnostics of rhinoviruses in the pathogenesis of allergic diseases B-37/2008.
Projects supported by European Comission:
2004–2009 - Framework 6: Rational design and standardized evaluation of novel genetic vaccines LSHB-2004-005246; participant.
2001–2006 - Framework 5: Combined immune and gene therapy for chronic viral hepatitis QLK2-2000-01476; participant.
|
| Languages: |
Lithuanian, English, Russian |
